Ichor Holdings offers a compelling risk/reward profile after a sharp valuation reset, trading at $57 despite strong ...
Ichor Holdings is benefiting from a semiconductor equipment demand recovery, driving strong revenue and margin growth. Learn ...
Ichor's fourth-quarter report arrived with sales and earnings that were better than Wall Street expected. The company expects sales will grow in a sequential basis in each quarter this year. Ichor ...
Hosted on MSN
Ichor forecasts Q2 revenue of $300M +/- $10M with 13%-14% gross margin as it targets at least 15%
CEO Philip Barros framed Q1 as early execution in what he called “a multiyear growth cycle,” saying, “Q1 revenues of $256 million came in at the upper end of our expectations, up 15% from Q4,” and ...
ICHR designs and manufactures fluid delivery subsystems, including gas and chemical delivery systems, as well as precision machined components for semiconductor capital equipment. It generates revenue ...
We are a leader in the design, engineering and manufacturing of critical fluid delivery subsystems and components primarily for semiconductor capital equipment, as well as other industries such as ...
SAN DIEGO--(BUSINESS WIRE)--Ichor Medical Systems, Inc. (Ichor) announced today that it has entered into a product development collaboration and worldwide license agreement with Janssen ...
SAN DIEGO--(BUSINESS WIRE)--Ichor Medical Systems, Inc. (Ichor) announced today the first in human dosing of JNJ-64300535 with its next generation investigational TriGrid ® Delivery System. This DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results